Truber Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
- Revenue Growth 90.87%
- Profit Growth -18.32%
- Ebitda 459.88%
- Net Worth 15.69%
- Total Assets 6.92%
About Truber Pharmaceutical
Truber Pharmaceutical Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 February 2019 (Five years and 11 months 23 days old ). Its registered office is in Neemuch, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.00 M.
Shaukin Lal, Sandeep Joshi, and Arvind Sharma serve as directors at the Company.
Company Details
-
Location
Neemuch, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51909MP2019PTC047846
-
Company No.
047846
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Feb 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Truber Pharmaceutical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shaukin Lal
|
Director | 19-Feb-2019 | Current |
|
Sandeep Joshi
|
Director | 19-Feb-2019 | Current |
|
Arvind Sharma
|
Director | 19-Feb-2019 | Current |
Financial Performance of Truber Pharmaceutical.
Truber Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 90.87% increase. The company also saw a substantial fall in profitability, with a 18.32% decrease in profit. The company's net worth Soared by an impressive increase of 15.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Truber Pharmaceutical?
Unlock access to Truber Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Aureum Healthcare Private LimitedShaukin Lal and Sandeep Joshi are mutual person
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Apr 2019 | Canara Bank | ₹1.00 M | Open |
How Many Employees Work at Truber Pharmaceutical?
Unlock and access historical data on people associated with Truber Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Truber Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Truber Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.